SC
Srijan Chatterjee
Research areas: Medicine · Infectious Diseases · SARS-CoV-2 and COVID-19 Research · COVID-19 Clinical Research Studies · Artificial Intelligence in Healthcare and Education
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (28)
- Autoantibodies in COVID‐19 and Other Viral Diseases: Molecular, Cellular, and Clinical Perspectives Save
- Large language model to multimodal large language model: A journey to shape the biological macromolecules to biological sciences and medicine Save
- Current landscape of long COVID clinical trials Save
- ChatGPT’s scorecard after the performance in a series of tests conducted at the multi-country level: A pattern of responses of generative artificial intelligence or large language models Save
- The landscape of neoantigens and its clinical applications: From immunobiology to cancer vaccines Save
- Therapeutic Potential of Quercetin as an Antioxidant for Bone-Muscle-Tendon Regeneration and Aging Save
- Antibody evasion associated with the RBD significant mutations in several emerging SARS-CoV-2 variants and its subvariants Save
- Can artificial intelligence-strengthened ChatGPT or other large language models transform nucleic acid research? Save
- Advances in Nanozymes as a Paradigm for Viral Diagnostics and Therapy Save
- Molnupiravir's mechanism of action drives "error catastrophe" in SARS-CoV-2: A therapeutic strategy that leads to lethal mutagenesis of the virus. Save
- Can the RBD mutation R346X provide an additional fitness to the “variant soup,” including offspring of BQ and XBB of SARS-CoV-2 Omicron for the antibody resistance? Save
- Resistance to nirmatrelvir due to mutations in the Mpro in the subvariants of SARS-CoV-2 Omicron: Another concern? Save
- Different cellular barriers to RNA therapeutics and strategies to overcome Save
- Bioactivity, Molecular Mechanism, and Targeted Delivery of Flavonoids for Bone Loss Save
- The D614G mutation helps to increase the transmissibility and reduce the virulence of SARS-CoV-2 variants through natural selection Save
- Therapeutic applications of nanobodies against SARS-CoV-2 and other viral infections: Current update Save
- A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies Save
- ChatGPT and large language models in orthopedics: from education and surgery to research Save
- An insight of different classes of RNA-based therapeutic, nanodelivery and clinical status: Current landscape Save
- Targeting Crosstalk of Signaling Pathways among Muscles-Bone-Adipose Tissue: A Promising Therapeutic Approach for Sarcopenia Save